HOME HEMODIALYSIS
MEET DIMI
The portability, flexibility and simplicity of the DIMI system facilitates dialysis in a wide variety of settings including hospitals, clinics, and skilled nursing facilities.
DIMI is indicated to treat patients with acute and/or chronic renal failure with or without fluid overload using hemodialysis (“HD”), hemodiafiltration (“HDF”), hemofiltration (“HF”) and/or ultrafiltration (“UF”) in hospital or clinical settings.
DIMI has Health Canada Approval.
The DIMI System has regulatory approval in the USA (cleared by FDA under 510(k) No. K193005). Dialco is actively seeking FDA approval for home hemodialysis (“HHD”) and peritoneal dialysis (“PD”) use.
DIMI has been developed and is manufactured and commercialized in partnership with Infomed SA.
DIMI Home Hemodialyisis
The portability, flexibility, and simplicity of the DIMI system.
Cappuccino with Claudio Ronco
39th Vicenza Course on Acute Kidney Injury (AKI) and Continuous Renal Replacement Therapy (CRRT) October 2021
CRRT Technology Update
Host: Dr. Claudio Ronco; Guest: Dr. John Kellum and SAMI
Cappuccino with Claudio Ronco
Dr. Ronco introduces the DIMI machine at the ERA-EDTA Nephrology Congress in Budapest, June 2019.